Researchers have found a way to better understand the heterogeneity of tumours in mice and patients through machine-learning models trained on PET-MRI data. In oncology, intratumoural heterogeneity, or the differences within a tumour, can impact the effectiveness of treatments. By using dynamic positron emission tomography (PET) and multiparametric magnetic resonance imaging (MRI), researchers were able to train classifiers to identify changes in tumour subtypes caused by targeted therapies in mice. They were also able to apply these classifiers to retrospective PET-MRI data from patients with liver metastases from colorectal cancer, which agreed with tumour histology. The ability to characterize intratumoural heterogeneity through machine-learning and multimodal imaging may lead to better precision oncology treatments.
Quantification of Tumor Variability in Mice and Patients using PET-MRI Machine-Learning Models – Nature Biomedical Engineering
Date:
Frequently Asked Questions (FAQs) Related to the Above News
Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.